Merck Sues To Stop Manufacture Of Generic Fosamax
In a move to protect its embattled market share for osteoporosis treatments, Merck and Co. Inc. has filed a lawsuit in federal court against Canadian generic drug manufacturer Apotex Inc. to...To view the full article, register now.
Already a subscriber? Click here to view full article